- Home
- MOLN vs ESSA Comparison
MOLN vs ESSA Comparison
Compare MOLN & ESSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOLN
- ESSA
- Stock Information
- Founded
- MOLN 2004
- ESSA 1916
- Country
- MOLN Switzerland
- ESSA United States
- Employees
- MOLN N/A
- ESSA N/A
- Industry
- MOLN
- ESSA Banks
- Sector
- MOLN
- ESSA Finance
- Exchange
- MOLN Nasdaq
- ESSA Nasdaq
- Market Cap
- MOLN 192.4M
- ESSA 195.3M
- IPO Year
- MOLN 2021
- ESSA N/A
- Fundamental
- Price
- MOLN $5.04
- ESSA $21.23
- Analyst Decision
- MOLN
- ESSA
- Analyst Count
- MOLN 0
- ESSA 0
- Target Price
- MOLN N/A
- ESSA N/A
- AVG Volume (30 Days)
- MOLN 5.7K
- ESSA 43.7K
- Earning Date
- MOLN 03-13-2025
- ESSA 01-29-2025
- Dividend Yield
- MOLN N/A
- ESSA 2.86%
- EPS Growth
- MOLN N/A
- ESSA N/A
- EPS
- MOLN N/A
- ESSA 1.74
- Revenue
- MOLN $7,105,397.00
- ESSA $67,430,000.00
- Revenue This Year
- MOLN N/A
- ESSA N/A
- Revenue Next Year
- MOLN $29.41
- ESSA N/A
- P/E Ratio
- MOLN N/A
- ESSA $11.94
- Revenue Growth
- MOLN N/A
- ESSA N/A
- 52 Week Low
- MOLN $3.32
- ESSA $15.29
- 52 Week High
- MOLN $12.70
- ESSA $21.62
- Technical
- Relative Strength Index (RSI)
- MOLN 41.97
- ESSA 58.98
- Support Level
- MOLN $5.22
- ESSA $20.77
- Resistance Level
- MOLN $5.35
- ESSA $21.62
- Average True Range (ATR)
- MOLN 0.12
- ESSA 0.51
- MACD
- MOLN -0.03
- ESSA 0.10
- Stochastic Oscillator
- MOLN 0.00
- ESSA 68.66
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About ESSA ESSA Bancorp Inc.
ESSA Bancorp Inc is a holding company, engaged in accepting deposits from the general public and investing those deposits, together with funds generated from operations and borrowings, in residential first mortgage loans (including construction mortgage loans), commercial real estate loans, home equity loans and lines of credit and commercial and industrial loans. The company offers a variety of deposit accounts, including checking, savings and certificates of deposit. The company also offers asset management and trust services and investment services. The company also offers insurance benefit consulting services through its wholly-owned subsidiary, ESSA Advisory Services, LLC.